Keratin 16 expression in epidermal melanocytes of normal human skin

被引:13
作者
Bhawan, J
Whren, K
Panova, I
Yaar, M
机构
[1] Boston Univ, Sch Med, Dept Dermatol, Dermatopathol Sect, Boston, MA 02118 USA
[2] Boston Univ, Sch Med, Dept Dermatol, Boston, MA 02118 USA
关键词
keratin; melanocytes; skin;
D O I
10.1097/01.dad.0000179627.81172.37
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Although the prevailing dogma states that keratin filaments are the hallmark of keratinocytes and other epithelial cells, recent publications suggest that they may be expressed by a variety of normal and malignant cells of different embryonic origin. Keratin expression has been reported in fibroblasts and endothelial cells as well as in various sarcomas. Also, some human melanomas express keratins in addition to the traditional diagnostic markers of differentiation, such as S-100 and melanocyte-specific antigens. Many studies have shown that cultured cells obtained from various melanomas express keratin. Most recently, keratin expression has also been shown in cultured melanocytes of normal skin. We now report that normal human melanocytes in vivo express keratin 16 (K 16) but not keratins 1, 5, 8, 10, 14, or even keratin 6, the type 11 partner that is normally expressed with K16 in keratinocytes. Similarly, melanocytes in vitro express K 16 but not K6. Keratin 16 expression in vivo was present in basal melanocytes in specimens derived from donors (0-77 years) and from different anatomic locations, suggesting that keratin 16 is constitutively expressed by all melanocytes. It appears that keratin expression may be more prevalent than previously assumed, and that these cytoskeletal filaments may play important roles in tissues and cells other than epithelia.
引用
收藏
页码:476 / 481
页数:6
相关论文
共 38 条
[1]   K16 expression in uninvolved psoriatic skin: a possible marker of pre-clinical psoriasis [J].
Bhawan, J ;
Bansal, C ;
Whren, K ;
Schwertschlag, U .
JOURNAL OF CUTANEOUS PATHOLOGY, 2004, 31 (07) :471-476
[2]  
BHAWAN J, 1994, MELANOMA RES, V4, P21
[3]   CYTOKERATIN EXPRESSION IN SMOOTH-MUSCLE AND SMOOTH-MUSCLE TUMORS [J].
BROWN, DC ;
THEAKER, JM ;
BANKS, PM ;
GATTER, KC ;
MASON, DY .
HISTOPATHOLOGY, 1987, 11 (05) :477-486
[4]   The epidermal phenotype during initiation of the psoriatic lesion in the symptomless margin of relapsing psoriasis [J].
Castelijns, FACM ;
Gerritsen, MJP ;
van Vlijmen-Willems, IMJJ ;
van Erp, PEJ ;
van de Kerkhof, PCM .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1999, 40 (06) :901-909
[5]   A study of cytokeratin profiles in localized cutaneous amyloids [J].
Chang, YT ;
Liu, HN ;
Wang, WJ ;
Lee, DD ;
Tsai, SF .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 2004, 296 (02) :83-88
[7]   RESPONSE OF PSORIASIS TO A NEW TOPICAL RETINOID, AGN-190168 [J].
ESGLEYESRIBOT, T ;
CHANDRARATNA, RA ;
LEWKAYA, DA ;
SEFTON, J ;
DUVIC, M .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1994, 30 (04) :581-590
[8]  
FUCHS U, 1992, AM J PATHOL, V141, P169
[9]   AN IMMUNOCYTOCHEMICAL STUDY OF MALIGNANT-MELANOMA AND ITS DIFFERENTIAL-DIAGNOSIS FROM OTHER MALIGNANT-TUMORS [J].
GATTER, KC ;
RALFKIAER, E ;
SKINNER, J ;
BROWN, D ;
HERYET, A ;
PULFORD, K ;
HOUJENSEN, K ;
MASON, D .
JOURNAL OF CLINICAL PATHOLOGY, 1985, 38 (12) :1353-1357